Home / News / Systagenix At Gargrave
Systagenix at Gargrave
Systagenix at Gargrave
History of Gargrave Facility
-
1780 Original woollen mill built
-
1924 Johnson & Johnson Limited established in the U.K.
-
1934 Gargrave site acquired by Johnson & Johnson
-
1960 Research & Development presence established
-
1973 Major facility extension
-
1992 Cobalt sterilisation unit commissioned
-
1995 Gargrave designated European Operations Centre
-
1997 Specialist biopolymers R&D group relocate to Gargrave
-
2003 U.S. A.W.C. & Biocides relocated to Gargrave
-
2004 Freeze Drying facility is validated
-
2007 New Technology Centre opens
-
2008 Johnson & Johnson divest Professional Wound Care business and
-
Systagenix Wound Management established
-
2009 Celebrating 75 years of Medical Device Manufacture
Total amount of major investments 2003 – 2009: $23.44MM
Gargrave Facility Workforce
-
Providing a broad range of skilled jobs in a rural economy
-
Manufacturing: 175
-
Engineering/Technology: 44
-
R&D, Regulatory & support functions: 112
-
Agency staff: 51
-
Total: 382
-
50 people with 25 years’ service & over
-
Supporting the local community
-
Community Action Group events
-
Supporting local charities
-
Supporting local schools and hospitals
-
-
Driving higher standard of care in the UK
-
One of the most penetrated markets in wound care
-
Gargrave continues to play a significant role
-
-
Sustaining UK’s strength in innovation
-
- Centre of Excellence for Wound Healing
19 Nov 2010
Legal Notice Privacy Policy © Copyright 2016, 2018, KCI Licensing, Inc. All rights reserved.